Results 211 to 220 of about 2,132,852 (328)
Editorial: The essential role of multidisciplinary teams in breast cancer surgery: collaboration for superior patient outcomes. [PDF]
Diaz R +5 more
europepmc +1 more source
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala +15 more
wiley +1 more source
Editorial: Cuproptosis and tumors, volume II: from basic research to clinical translation. [PDF]
Liu B, Wang C, Liu J, Xu C, Bu LL.
europepmc +1 more source
Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity
Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung +17 more
wiley +1 more source
Dialogical meanderings - evaluation framework and learnings from stakeholder involvement in the co-design of a participatory systematic review. [PDF]
Ruiz-Perez G +4 more
europepmc +1 more source
This study shows that copy number variations (CNVs) can be reliably detected in formalin‐fixed paraffin‐embedded (FFPE) solid cancer samples using ultra‐low‐pass whole‐genome sequencing, provided that key (pre)‐analytical parameters are optimized.
Hanne Goris +10 more
wiley +1 more source
Editorial: Methodological and technical issues of tele-neuropsychology: remote cognitive assessment and intervention across the life span. [PDF]
Veronelli L, Sperling SA, Mondini S.
europepmc +1 more source

